Skip Ribbon Commands
Skip to main content

Dr Chandramouli Nagarajan


Senior Consultant

Singapore General Hospital

Specialty: Haematology, Haematology

Sub-specialties: Lymphoma, Myeloma

Conditions Treated by this Doctor:
Chronic Lymphocytic Leukemia (CLL), Lymphoma.

Clinical Appointments

  • Myeloma Services Singapore General HospitalSingapore General Hospital
  • Senior Consultant SingHealth Duke-NUS Blood Cancer Centre
  • Senior Consultant SingHealth Duke-NUS Transplant Centre
  • Senior Consultant Haematology Singapore General HospitalSingapore General Hospital


Following the completion of Medical Undergraduate training in Chennai, Dr. Chandramouli Nagarajan joined the prestigious Post Graduate Institute of Medical Education and Research (PGIMER), Chandigarh, India where he completed the 3 years Internal Medicine residency programme and was awarded MD (Internal Medicine).
He then moved to the UK for further medical speciality training. After obtaining MRCP and gaining experience in Haematology in University Hospital of Wales, Cardiff and Newcastle upon Tyne Hospitals, he entered the 5 year Haematology speciality training programme with the East Midlands Deanery. He completed FRCPath and received the Certificate of completion of specialist training (CCST).

He served as a Consultant Haematologist at Warrington & Halton Hospitals NHS Foundation trust in the North West of England for 2 1/2 years before moving to Singapore. He has contributed as a member of several committees, was the clinical lead for blood transfusion services and has been involved in research, serving as a principal investigator for clinical trial during his tenure at Warrington.

His main area of interest is malignant Haematology especially Lymphomas, Myeloma as well as Immune and Laboratory Haematology. He is currently the Director for Myeloma Services at SGH.  His other area of interest is clinical / medical education and he has been actively involved in undergraduate and postgraduate education throughout his career. He currently holds educational appointments as a Senior Lecturer at the Yong Loo Lin School of Medicine and as an Adjunct assistant professor at the Duke NUS Medical School. He was appointed as the Programme Director for the SingHealth Haematology Residency in Jan 2018.

He was elected to the Fellowship of the Royal College of Physicians (FRCP), Edinburgh in 2014. He is a registered member of Indian Medical Association, is on the Specialist Register of the General Medical Council, UK and Singapore Medical council and is a member of the European Haematology Association.


  • ​FRCP (Edin) 
  • FRCPath Haematology UK
  • MRCP (UK)
  • MD (Internal Medicine)
  • MBBS 

Professional Appointments and Committee Memberships

  • Programme Director (Haematology) SingHealth Residency Programme
  • Director of Myeloma Services
  • Previously Core Faculty and currently Programme Director for SingHealth Haematology Residency


  • Service with a Heart
  • Singapore Health Quality Service award March 2017
  • Outstanding Residency Faculty award (RiSE)2017

Research Interests


  • Perianal Streptococcal Dermatitis. Balasubramanian S, Padmasini LN, Mouli NC (2000). Indian Paediatrics. Apr; 37(4): 433-5.
  • Higher Bifurcation of the Common Carotid Artery. Melanie R.S, Nivedha.S, Chandramouli, Ashokka, S.Rajamanickam, (2001) Anatomical Adjuncts.;Vol.3, No. 1:35-39
  • A pruritic rash in a patient with Hodgkin lymphoma. R. C. Simpson, P. Da Forno, C. Nagarajan, K. E. Harman (2011). Clinical and experimental dermatology, Volume 36, Issue 6, August : 680–682
  • Circulating tumour cells in disseminated malignant melanoma. Nagarajan C., Barbieri, A. and Mittal, S. (2012). British Journal of Haematology, 156: 692. doi: 10.1111/j.1365-2141.2011.09004.x 
  • Thrombotic microangiopathy during Carfilzomib use, Case series in Singapore (2016). Sathish Gopalakrishnan, Yunxin Chen, Melissa Ooi, Adeline Lin, Joanne Lee, Chandramouli Nagarajan et al. Blood Cancer J  6: e450; 10.1038/bcj.2016.62
  • The Singapore Myeloma Study Group Consensus Guidelines for the management of patients with multiple myeloma (2016). Sanjay de Mel, Yunxin Chen, Sathish Kumar Gopalakrishnan, Melissa Ooi, Constance Teo, Daryl Tan, Min Li Claire Teo, Allison CY Tso, Lian King Lee, Chandramouli Nagarajan, Yeow Tee Goh, Wee Joo Chng. Singapore Med J. 2017 Feb; 58(2):55-71
  • Durable remission is achievable with localized treatment and reduction of immunosuppression in limited stage EBV-related plasmablastic lymphoma. C. Phipps, K.W. Yeoh, Y.S. Lee, C. Nagarajan, et al. Ann Hematol. 2017 Nov; 96(11):1959-1960 
  • Terminal care in Haematological Disease – Chapter in a new Textbook of Medicine by OUP – awaiting publication (due 2018)

Research Trials